PTC Therapeutics, Inc. (PTCT)
USD 43.4
(-7.14%)
USD 43.4
(-7.14%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -178.97 Million USD | -161.1% |
| 2022 | 292.92 Million USD | 185.66% |
| 2021 | -341.94 Million USD | -261.58% |
| 2020 | 211.62 Million USD | 156.78% |
| 2019 | -372.7 Million USD | -399.79% |
| 2018 | -74.57 Million USD | -61.15% |
| 2017 | -46.27 Million USD | 65.32% |
| 2016 | -133.45 Million USD | 45.38% |
| 2015 | -244.31 Million USD | 22.5% |
| 2014 | -315.24 Million USD | -1951.58% |
| 2013 | -15.36 Million USD | -812.28% |
| 2012 | 2.15 Million USD | 112.89% |
| 2011 | -16.74 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -126.91 Million USD | 29.09% |
| 2024 Q2 | -259.27 Million USD | -104.3% |
| 2023 Q2 | 494.28 Million USD | -7.38% |
| 2023 Q4 | -178.97 Million USD | -133.19% |
| 2023 FY | -178.97 Million USD | -161.1% |
| 2023 Q3 | 539.19 Million USD | 9.09% |
| 2023 Q1 | 533.67 Million USD | 82.19% |
| 2022 Q2 | 441.31 Million USD | 13.75% |
| 2022 Q3 | 310.6 Million USD | -29.62% |
| 2022 Q4 | 292.92 Million USD | -5.69% |
| 2022 FY | 292.92 Million USD | 185.66% |
| 2022 Q1 | 387.96 Million USD | 213.46% |
| 2021 Q2 | 359.08 Million USD | -8.01% |
| 2021 Q3 | 345.72 Million USD | -3.72% |
| 2021 Q1 | 390.34 Million USD | 84.45% |
| 2021 FY | -341.94 Million USD | -261.58% |
| 2021 Q4 | -341.94 Million USD | -198.91% |
| 2020 Q1 | 191.28 Million USD | 151.32% |
| 2020 Q4 | 211.62 Million USD | 1179.34% |
| 2020 Q3 | -19.6 Million USD | -110.71% |
| 2020 Q2 | 183.11 Million USD | -4.27% |
| 2020 FY | 211.62 Million USD | 156.78% |
| 2019 Q4 | -372.7 Million USD | -77.12% |
| 2019 Q2 | 19.58 Million USD | 107.77% |
| 2019 Q3 | -210.42 Million USD | -1174.22% |
| 2019 Q1 | -252.02 Million USD | -237.96% |
| 2019 FY | -372.7 Million USD | -399.79% |
| 2018 FY | -74.57 Million USD | -61.15% |
| 2018 Q3 | -55.98 Million USD | 25.27% |
| 2018 Q2 | -74.91 Million USD | -252.26% |
| 2018 Q1 | 49.2 Million USD | 206.33% |
| 2018 Q4 | -74.57 Million USD | -33.19% |
| 2017 Q2 | -39.82 Million USD | -186.98% |
| 2017 Q4 | -46.27 Million USD | -3793.14% |
| 2017 FY | -46.27 Million USD | 65.32% |
| 2017 Q1 | 45.78 Million USD | 134.31% |
| 2017 Q3 | 1.25 Million USD | 103.15% |
| 2016 Q1 | 53.2 Million USD | 121.78% |
| 2016 FY | -133.45 Million USD | 45.38% |
| 2016 Q4 | -133.45 Million USD | -388.4% |
| 2016 Q3 | 46.27 Million USD | -21.94% |
| 2016 Q2 | 59.27 Million USD | 11.42% |
| 2015 FY | -244.31 Million USD | 22.5% |
| 2015 Q4 | -244.31 Million USD | -414.2% |
| 2015 Q3 | -47.51 Million USD | 81.38% |
| 2015 Q2 | -255.21 Million USD | 9.0% |
| 2015 Q1 | -280.46 Million USD | 11.03% |
| 2014 Q4 | -315.24 Million USD | -496.22% |
| 2014 FY | -315.24 Million USD | -1951.58% |
| 2014 Q1 | -115.84 Million USD | -653.9% |
| 2014 Q3 | -52.87 Million USD | -149.73% |
| 2014 Q2 | -21.17 Million USD | 81.72% |
| 2013 Q3 | -23.96 Million USD | 85.29% |
| 2013 Q4 | -15.36 Million USD | 35.87% |
| 2013 FY | -15.36 Million USD | -812.28% |
| 2013 Q1 | -50.91 Million USD | -2459.97% |
| 2013 Q2 | -162.93 Million USD | -220.03% |
| 2012 FY | 2.15 Million USD | 112.89% |
| 2012 Q4 | 2.15 Million USD | 0.0% |
| 2011 FY | -16.74 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -219.941% |
| Alkermes plc | -166.73 Million USD | -7.338% |
| Agenus Inc. | 274.13 Million USD | 165.287% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 109.571% |
| Aptorum Group Limited | 1.35 Million USD | 13288.573% |
| Ardelyx, Inc. | 34.51 Million USD | 618.588% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4281.659% |
| Bicycle Therapeutics plc | -481.46 Million USD | 62.827% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 594.912% |
| ChromaDex Corporation | -24.04 Million USD | -644.241% |
| Chimerix, Inc. | -25.51 Million USD | -601.395% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2668.5% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -655.902% |
| CRISPR Therapeutics AG | -150.84 Million USD | -18.648% |
| Precision BioSciences, Inc. | -85.41 Million USD | -109.548% |
| Dyadic International, Inc. | -6.37 Million USD | -2706.087% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1023.298% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2434.964% |
| Lantern Pharma Inc. | -21.7 Million USD | -724.645% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -61.914% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1994.947% |
| Incyte Corporation | -3.17 Billion USD | 94.363% |
| IO Biotech, Inc. | -140.69 Million USD | -27.204% |
| Jaguar Health, Inc. | 29.39 Million USD | 708.945% |
| Novavax, Inc. | -298.29 Million USD | 40.0% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3453.476% |
| Opthea Limited | 28.15 Million USD | 735.622% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -966.025% |
| ContextLogic Inc. | -232 Million USD | 22.856% |
| MiMedx Group, Inc. | -33.9 Million USD | -427.934% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1855.517% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -7624.338% |
| NextCure, Inc. | -6.47 Million USD | -2663.239% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -254.399% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2705.691% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1571.439% |
| Vaxcyte, Inc. | -368.22 Million USD | 51.395% |
| PDS Biotechnology Corporation | -32.7 Million USD | -447.175% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1135.855% |
| Pharming Group N.V. | 109.8 Million USD | 262.995% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -928.828% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -2.137% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -866.395% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -866.395% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2420.775% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2954.181% |
| Acelyrin, Inc. | -216.9 Million USD | 17.486% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3090.133% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -10281.381% |
| Summit Therapeutics Inc. | 34.67 Million USD | 616.165% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2530.825% |
| Senti Biosciences, Inc. | 1.74 Million USD | 10385.92% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 3.051% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -131.082% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2852.408% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 179489.389% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 28599.204% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -52.91% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -6.385% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 261.428% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2256.174% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -38.618% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2695.873% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 26.154% |
| Immix Biopharma, Inc. | -17.5 Million USD | -922.142% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 43.488% |
| MEI Pharma, Inc. | -3.7 Million USD | -4730.634% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1530.541% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 210.655% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 743.957% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2434.964% |
| Precigen, Inc. | -481 Thousand USD | -37108.94% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1371.039% |
| AlloVir, Inc. | -62.69 Million USD | -185.483% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -221.816% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 390.233% |
| ImmuCell Corporation | 10.99 Million USD | 1728.443% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -16.107% |
| Onconetix, Inc. | 5.33 Million USD | 3456.975% |
| PureTech Health plc | -167.19 Million USD | -7.044% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -487.574% |
| Elevation Oncology, Inc. | -19.11 Million USD | -836.16% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3545.855% |
| Seer, Inc. | -4.24 Million USD | -4121.108% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -644.581% |
| Innoviva, Inc. | 255.56 Million USD | 170.032% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -220.376% |
| ESSA Pharma Inc. | -33.62 Million USD | -432.322% |
| GlycoMimetics, Inc. | -40.98 Million USD | -336.69% |
| GT Biopharma, Inc. | -1.02 Million USD | -17429.383% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -164.041% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 392.171% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -33.485% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1191.679% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -519.891% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -237475.331% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -479.92% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2083.992% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -5619.846% |
| Soligenix, Inc. | -4.95 Million USD | -3514.49% |
| Century Therapeutics, Inc. | 847 Thousand USD | 21230.46% |
| Kura Oncology, Inc. | -20.11 Million USD | -789.626% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -337.314% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2031.162% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 9924.641% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -5498.217% |
| Autolus Therapeutics plc | -186.59 Million USD | 4.086% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -263.003% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 35.106% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 622.28% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 208.887% |
| GRI Bio, Inc. | -1.79 Million USD | -9876.31% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1892.364% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -438.157% |
| IGM Biosciences, Inc. | -72.6 Million USD | -146.502% |
| INmune Bio, Inc. | -25.41 Million USD | -604.321% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 218.565% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -253.294% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1001.427% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -6103.799% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 570.801% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -334.564% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 661.314% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 147.354% |
| Verastem, Inc. | -37.27 Million USD | -380.109% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1872.611% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -245.099% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1082.524% |
| Histogen Inc. | -7.48 Million USD | -2290.477% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -728.326% |
| Surrozen, Inc. | -32.66 Million USD | -447.927% |
| Organovo Holdings, Inc. | -1.5 Million USD | -11776.244% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4157.774% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1043.951% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 6941.552% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4406.424% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2035.447% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -311.986% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1127.802% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 43.503% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -24686.721% |
| Apollomics, Inc. | -27.39 Million USD | -553.313% |
| Amarin Corporation plc | -191.04 Million USD | 6.315% |
| Mesoblast Limited | 55.96 Million USD | 419.81% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1127.201% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -607.635% |
| Synaptogenix, Inc. | -28.66 Million USD | -524.444% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -19021.261% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 467.264% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -20660.618% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2363.158% |
| Exelixis, Inc. | -73.05 Million USD | -145.003% |
| Better Therapeutics, Inc. | -860 Thousand USD | -20711.047% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -645.325% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 25.851% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 24415.075% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2306.181% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 14372.329% |
| Gritstone bio, Inc. | 39.49 Million USD | 553.216% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -112.81% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -6699.6% |
| Avid Bioservices, Inc. | 169.72 Million USD | 205.448% |
| Insmed Incorporated | 721.62 Million USD | 124.802% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1857.827% |
| MediWound Ltd. | -5.32 Million USD | -3262.927% |
| OmniAb, Inc. | 9.2 Million USD | 2044.746% |
| Alector, Inc. | -35.63 Million USD | -402.217% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 308.181% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3531.798% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1451.877% |
| Zai Lab Limited | -775 Million USD | 76.906% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 152.554% |
| Aura Biosciences, Inc. | -21.52 Million USD | -731.475% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -116.992% |
| Immunic, Inc. | -45.34 Million USD | -294.74% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 7.37% |
| Veracyte, Inc. | -203.82 Million USD | 12.191% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 128.04% |
| FibroGen, Inc. | 56.76 Million USD | 415.28% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2109.826% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -6230.733% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -8544.682% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 103.899% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -5256.929% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -7.84% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1101.987% |
| Galecto, Inc. | -21.21 Million USD | -743.585% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -652.47% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 111.404% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -631.346% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1455.358% |
| XBiotech Inc. | -200.02 Million USD | 10.523% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -112.81% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 4052.628% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -407.543% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -131.779% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3244.878% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -5.023% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -93.75% |
| Vaxxinity, Inc. | 10.13 Million USD | 1866.433% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 124.308% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1562.17% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -171.355% |
| NexImmune, Inc. | -3.13 Million USD | -5611.404% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -5083.665% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1084.367% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -560.424% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1893.916% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -143568.473% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -341.129% |
| Ainos, Inc. | 4.07 Million USD | 4488.871% |
| Pluri Inc. | 22.82 Million USD | 883.981% |
| Prothena Corporation plc | -608.34 Million USD | 70.58% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -50.708% |
| Celularity Inc. | 65.19 Million USD | 374.544% |
| Rallybio Corporation | -24.1 Million USD | -642.573% |
| Cue Biopharma, Inc. | -33.81 Million USD | -429.214% |
| MeiraGTx Holdings plc | -40.3 Million USD | -344.085% |
| Omeros Corporation | 331.17 Million USD | 154.042% |
| Humacyte, Inc. | -22.48 Million USD | -695.94% |
| Immunocore Holdings plc | -358.59 Million USD | 50.09% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -628.281% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -479.188% |
| Blueprint Medicines Corporation | 702.83 Million USD | 125.465% |
| CalciMedica, Inc. | -5.53 Million USD | -3136.438% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 4.912% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1652.252% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -347.024% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -438.222% |
| Pulmatrix, Inc. | -10.41 Million USD | -1618.105% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2894.395% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -369.233% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -60.657% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -198.57% |
| Cytokinetics, Incorporated | 642.37 Million USD | 127.862% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2973.587% |
| Nutriband Inc. | -251.65 Thousand USD | -71018.626% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -424.561% |
| Vor Biopharma Inc. | 4.3 Million USD | 4262.209% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.035% |
| Evogene Ltd. | -19.63 Million USD | -811.556% |
| ProKidney Corp. | -56.23 Million USD | -218.257% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -267.717% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1837.549% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 113.122% |
| CorMedix Inc. | -43.05 Million USD | -315.713% |
| BioLineRx Ltd. | 7.33 Million USD | 2539.681% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -551.648% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 487.837% |
| Atai Life Sciences N.V. | -28.55 Million USD | -526.707% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 8123.881% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -684.428% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1109.163% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -138.398% |
| MediciNova, Inc. | -50.78 Million USD | -252.427% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -127.111% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -795521.249% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2673.693% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 10.432% |
| Biomea Fusion, Inc. | -166.57 Million USD | -7.447% |
| Mereo BioPharma Group plc | -51.46 Million USD | -247.734% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -88.705% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 39.074% |
| Absci Corporation | -72.59 Million USD | -146.529% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4019.733% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 23.658% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -89.973% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -87.025% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -358.053% |
| Allakos Inc. | -24.97 Million USD | -616.617% |
| Imunon, Inc. | -4.21 Million USD | -4147.302% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1114.048% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -32.182% |
| BioAtla, Inc. | -109.01 Million USD | -64.181% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 24415.075% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -18960.17% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1595.696% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -744.102% |
| XOMA Corporation | -29 Million USD | -517.155% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -980.767% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1885.082% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2302.671% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -43.598% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 14.022% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -118.852% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -92.938% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -20730.812% |
| Akari Therapeutics, Plc | -3.84 Million USD | -4554.746% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 11128.166% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 112.961% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -14963.524% |
| UroGen Pharma Ltd. | 4.39 Million USD | 4175.951% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 257.714% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 248807.651% |
| Orgenesis Inc. | 21.78 Million USD | 921.589% |
| Entera Bio Ltd. | -10.62 Million USD | -1583.837% |
| GH Research PLC | -78.07 Million USD | -129.229% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -703.011% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -571.349% |
| Xencor, Inc. | 29.64 Million USD | 703.748% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -8985.892% |
| Replimune Group, Inc. | 1.41 Million USD | 12775.283% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -72978.462% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -41.575% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -14963.524% |
| Portage Biotech Inc. | -4.98 Million USD | -3493.154% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -795521.249% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -170.674% |
| OncoCyte Corporation | -6.56 Million USD | -2627.03% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 20043.437% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -3828.644% |
| Purple Biotech Ltd. | -14.13 Million USD | -1165.915% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -653.389% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2634.53% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -972.21% |
| HilleVax, Inc. | -165.48 Million USD | -8.152% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -6951.812% |
| Tharimmune, Inc. | -10.93 Million USD | -1536.664% |
| Genprex, Inc. | -6.73 Million USD | -2556.35% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 51.472% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -102.323% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -12674.804% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -5295.777% |
| OKYO Pharma Limited | -826.84 Thousand USD | -21545.454% |
| Savara Inc. | 153 Thousand USD | 117077.124% |
| Curis, Inc. | -23.88 Million USD | -649.257% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3369.913% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -22963.432% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2782.974% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 15203.376% |
| BeiGene, Ltd. | -2.25 Billion USD | 92.056% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1550.541% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 70.573% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 3.562% |
| Erasca, Inc. | -37.21 Million USD | -380.909% |
| bluebird bio, Inc. | 108.57 Million USD | 264.846% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -13796.729% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 147.254% |
| DBV Technologies S.A. | -126.98 Million USD | -40.941% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -13796.729% |
| Moderna, Inc. | -2.9 Billion USD | 93.843% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1628.893% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1546.807% |
| Molecular Templates, Inc. | 707 Thousand USD | 25414.71% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -470.511% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 151.636% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -118.097% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -95.111% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -454.583% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -420.639% |
| MacroGenics, Inc. | -66.98 Million USD | -167.187% |
| RenovoRx, Inc. | -1.17 Million USD | -15157.886% |
| Adicet Bio, Inc. | -138.78 Million USD | -28.957% |
| Prime Medicine, Inc. | -27.94 Million USD | -540.546% |
| Aditxt, Inc. | 18.12 Million USD | 1087.673% |
| Adagene Inc. | -87.62 Million USD | -104.246% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4196.677% |
| Quantum-Si incorporated | -118.55 Million USD | -50.961% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 597.084% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2294.575% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -268.952% |
| SciSparc Ltd. | -2.06 Million USD | -8567.07% |
| Vericel Corporation | 1.27 Million USD | 14115.27% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1392.491% |
| Minerva Neurosciences, Inc. | 41 Million USD | 536.479% |
| Generation Bio Co. | 31.44 Million USD | 669.114% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -2.059% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -478.776% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 253.504% |
| Invivyd, Inc. | -198.47 Million USD | 9.825% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -98.266% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -7364.482% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -152.825% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2522.344% |
| 2seventy bio, Inc. | 181.71 Million USD | 198.492% |
| ADMA Biologics, Inc. | 90.06 Million USD | 298.715% |
| Clene Inc. | 3.34 Million USD | 5458.533% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1870.504% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -732.016% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2673.693% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 47.991% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -588.374% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 200.737% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4274.241% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3678.069% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3335.88% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -37.352% |
| Evaxion Biotech A/S | 5.28 Million USD | 3485.29% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -58.993% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -36.338% |
| Trevena, Inc. | 2.25 Million USD | 8026.262% |
| Surrozen, Inc. | -32.66 Million USD | -447.927% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -247.457% |
| Cingulate Inc. | 3.08 Million USD | 5905.819% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -5993.803% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2590.26% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1826.279% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -125.628% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -36.152% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -69.577% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4439.474% |
| Kronos Bio, Inc. | -36.05 Million USD | -396.408% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2002.168% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 12374.308% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -229.871% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1341.468% |
| ImmunityBio, Inc. | 618.22 Million USD | 128.95% |
| Korro Bio, Inc. | -132.94 Million USD | -34.625% |
| Kineta, Inc. | -4.54 Million USD | -3841.312% |
| BioVie Inc. | -17.73 Million USD | -909.313% |
| Codexis, Inc. | -43.27 Million USD | -313.614% |
| Celularity Inc. | 65.19 Million USD | 374.544% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -5547.681% |
| Celcuity Inc. | 6.78 Million USD | 2738.384% |
| Virax Biolabs Group Limited | -3.36 Million USD | -5218.811% |
| Cibus, Inc. | -8.07 Million USD | -2115.586% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -4132.088% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 4016.302% |
| IN8bio, Inc. | -16.38 Million USD | -992.043% |
| Kodiak Sciences Inc. | -103.87 Million USD | -72.298% |
| Annexon, Inc. | -193.75 Million USD | 7.628% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 497252.778% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -922.773% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -4994.648% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 116.976% |
| Eyenovia, Inc. | 1.25 Million USD | 14319.013% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 765.211% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5418.81% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -438.319% |
| Arcellx, Inc. | -296.95 Million USD | 39.731% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -817.538% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -203.992% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -763.487% |
| Moolec Science SA | 117.61 Thousand USD | 152268.923% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -366.093% |
| Geron Corporation | 14.76 Million USD | 1312.486% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -372.005% |
| Royalty Pharma plc | 5.65 Billion USD | 103.163% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -26.555% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2460.654% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3237.306% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -27.175% |
| Humacyte, Inc. | -22.48 Million USD | -695.94% |
| Structure Therapeutics Inc. | -124.33 Million USD | -43.941% |
| 89bio, Inc. | -289.05 Million USD | 38.082% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -609.037% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -9937.858% |
| Genelux Corporation | -6.89 Million USD | -2494.217% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -476.242% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 314.087% |
| Notable Labs, Ltd. | -9.77 Million USD | -1730.759% |
| Liquidia Corporation | -80.17 Million USD | -123.228% |
| Mustang Bio, Inc. | -3.73 Million USD | -4690.551% |
| Immunovant, Inc. | -635.22 Million USD | 71.825% |
| Quantum-Si incorporated | -118.55 Million USD | -50.961% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -918.988% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -4219.937% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2329.662% |
| Acasti Pharma Inc. | -23 Million USD | -677.983% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -5215.201% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1001.427% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -29.937% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -5643.075% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -705.033% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -863.838% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -5.728% |
| PepGen Inc. | -60.67 Million USD | -194.998% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -678.965% |
| United Therapeutics Corporation | -507.7 Million USD | 64.748% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -835.768% |
| Solid Biosciences Inc. | -47.75 Million USD | -274.817% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -20660.618% |
| Immuneering Corporation | -54.94 Million USD | -225.748% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4157.774% |
| Silo Pharma, Inc. | -3.52 Million USD | -4978.302% |
| Belite Bio, Inc | -87.27 Million USD | -105.08% |
| XOMA Corporation | -29 Million USD | -517.155% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -153.158% |
| Bionomics Limited | 227 Million USD | 178.84% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -53.915% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6965.732% |
| uniQure N.V. | -102.95 Million USD | -73.845% |
| Cassava Sciences, Inc. | -121.13 Million USD | -47.747% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4196.677% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 537.047% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1396.321% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -5684.209% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 168944.34% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5418.81% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2109.826% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2313.363% |
| Altimmune, Inc. | -134.48 Million USD | -33.08% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 190.362% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6965.732% |
| Compugen Ltd. | -12.9 Million USD | -1286.973% |
| Peak Bio, Inc. | 10.34 Million USD | 1830.873% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -63142.049% |
| Benitec Biopharma Inc. | -50.58 Million USD | -253.831% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -71.534% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1011.046% |
| Zura Bio Limited | -99.8 Million USD | -79.323% |
| PolyPid Ltd. | 6.17 Million USD | 3000.729% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 341.467% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1011.046% |
| Instil Bio, Inc. | 75.35 Million USD | 337.5% |
| argenx SE | -2.02 Billion USD | 91.178% |
| Immunome, Inc. | -97.02 Million USD | -84.455% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -695.621% |
| Verona Pharma plc | -220.44 Million USD | 18.811% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -149.467% |
| Shattuck Labs, Inc. | -121.42 Million USD | -47.397% |
| CervoMed Inc. | -7.79 Million USD | -2196.658% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 3.517% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -3992.728% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -35.855% |
| Moolec Science SA | 117.61 Thousand USD | 152268.923% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -7722.413% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1225.744% |
| AnaptysBio, Inc. | -18.15 Million USD | -886.034% |
| Design Therapeutics, Inc. | -18.15 Million USD | -886.088% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -154.294% |
| NeurAxis, Inc. | 145.7 Thousand USD | 122938.023% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1693.438% |
| Lumos Pharma, Inc. | -28.49 Million USD | -528.137% |
| Achilles Therapeutics plc | -126.92 Million USD | -41.01% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -149.467% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -27194.008% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -761.541% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 12374.308% |
| Nutriband Inc. | -251.65 Thousand USD | -71018.626% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1258.857% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2305.578% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 152.609% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 854.055% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 60.003% |
| Palisade Bio, Inc. | -12.06 Million USD | -1383.669% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -27.556% |
| Beam Therapeutics Inc. | -262.72 Million USD | 31.877% |
| Neurogene Inc. | -131.95 Million USD | -35.633% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 920.384% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3567.52% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 52.551% |
| Sesen Bio, Inc. | -112.55 Million USD | -59.014% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -79.226% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -7523.117% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -358.605% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -114.902% |
| Athira Pharma, Inc. | -88.99 Million USD | -101.098% |
| Vaccinex, Inc. | -1.28 Million USD | -13795.575% |
| HCW Biologics Inc. | 2.85 Million USD | 6365.149% |
| XOMA Corporation | -29 Million USD | -517.155% |
| Nektar Therapeutics | 210.24 Million USD | 185.129% |
| Arvinas, Inc. | -313.8 Million USD | 42.965% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 11128.166% |
| Merus N.V. | -192.88 Million USD | 7.211% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 398.366% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2479.634% |
| Rezolute, Inc. | -68.16 Million USD | -162.55% |
| Clene Inc. | 3.34 Million USD | 5458.533% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1257.208% |
| BeyondSpring Inc. | -13.75 Million USD | -1201.163% |
| Synlogic, Inc. | -6.68 Million USD | -2577.263% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 15882.628% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2016.795% |
| Peak Bio, Inc. | 10.34 Million USD | 1830.873% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -117.15% |
| Krystal Biotech, Inc. | -350.23 Million USD | 48.898% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 244.189% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -5.905% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -5568.889% |
| MannKind Corporation | 143.89 Million USD | 224.375% |
| Ikena Oncology, Inc. | -109.15 Million USD | -63.963% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2263.955% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -440.71% |
| Gossamer Bio, Inc. | 180.35 Million USD | 199.235% |
| CohBar, Inc. | -5.93 Million USD | -2917.756% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -501.637% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4019.733% |
| Legend Biotech Corporation | -949.39 Million USD | 81.149% |
| Mural Oncology plc | -255.84 Million USD | 30.045% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 655.564% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -3699.376% |
| Disc Medicine, Inc. | -358.28 Million USD | 50.046% |
| Champions Oncology, Inc. | 4.81 Million USD | 3819.347% |
| REGENXBIO Inc. | 54.76 Million USD | 426.788% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -66456.467% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -18.508% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1885.962% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -121.825% |
| Vaxart, Inc. | -8.24 Million USD | -2071.763% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -256.666% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -40.742% |
| Cellectis S.A. | -43.85 Million USD | -308.106% |
| Longeveron Inc. | -2.9 Million USD | -6054.574% |
| Repare Therapeutics Inc. | -107.85 Million USD | -65.936% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 118.482% |
| Inozyme Pharma, Inc. | 12 Million USD | 1590.961% |
| Revolution Medicines, Inc. | -608.2 Million USD | 70.573% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -14450.813% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 32.492% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -19.259% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1043.829% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -24085.811% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.129% |
| Denali Therapeutics Inc. | -74.86 Million USD | -139.064% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1392.491% |
| Veru Inc. | 4.77 Million USD | 3844.271% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1491.455% |
| Cingulate Inc. | 3.08 Million USD | 5905.819% |
| Passage Bio, Inc. | 4.58 Million USD | 4003.49% |
| Context Therapeutics Inc. | -14.44 Million USD | -1138.596% |
| Exicure, Inc. | 5.84 Million USD | 3159.925% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 22.312% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -352.3% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1240.622% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -204.271% |
| Nuvalent, Inc. | -335.38 Million USD | 46.636% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 10419.482% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -140.293% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1913.217% |
| OmniAb, Inc. | 9.2 Million USD | 2044.746% |
| Anew Medical, Inc. | 1.43 Million USD | 12594.197% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1192.526% |
| Lipocine Inc. | -4.75 Million USD | -3664.256% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -62.959% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1275.071% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -253.294% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 819.006% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2562.922% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -171.887% |
| Ocugen, Inc. | -32.52 Million USD | -450.337% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -109.144% |
| Q32 Bio Inc. | -37.94 Million USD | -371.632% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -28399.204% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1222.899% |
| Equillium, Inc. | -22.39 Million USD | -699.281% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -599.996% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -448.553% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -72092.082% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 233.522% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 5696.467% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 54592.283% |
| Dominari Holdings Inc. | 195 Thousand USD | 91882.051% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3298.102% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1907.121% |
| Bio-Techne Corporation | 267.74 Million USD | 166.845% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1004.171% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -51.553% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2029.894% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1314.71% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 26.984% |
| Nkarta, Inc. | 57.29 Million USD | 412.353% |
| BioCardia, Inc. | 212 Thousand USD | 84522.17% |
| Iterum Therapeutics plc | 13.43 Million USD | 1431.857% |